Structure Therapeutics Inc (GPCR)

Structure Therapeutics Inc. witnessed limited insider activity recently, with a single officer filing a proposed sale of 4,008 shares valued at $140,280 in September 2026. This follows a period where the stock price declined significantly by 62.2% over the last quarter, despite a positive earnings report surprise of 27.45% recorded in November.
Ticker: GPCR Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
BLAS COLL CRESPO Officer Officer
Transaction date
Proposed sale
Price
80.28
Quantity 26,359
Value US$2,098,595
XICHEN LIN Officer Officer
Transaction date
Proposed sale
Price
381.28
Quantity 35,808
Value US$4,904,179
3.0
RAYMOND C STEVENS Officer Officer
Transaction date
Proposed sale
Price
244.71
Quantity 95,665
Value US$3,966,784
XICHEN LIN Officer Officer
Transaction date
Proposed sale
Price
34.20
Quantity 59,000
Value US$2,017,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-21 2026-09-21 PrS Proposed sale

Officer

Officer
26,359
80.28
US$2,098,595
26,359 80.28 US$2,098,595
2026-06-25 2026-06-25 PrS Proposed sale

Officer

Officer
35,808
381.28
US$4,904,179
35,808 381.28 US$4,904,179
2024-06-10 2024-06-10 PrS Proposed sale

Officer

Officer
95,665
244.71
US$3,966,784
95,665 244.71 US$3,966,784
2024-06-03 2024-06-03 PrS Proposed sale

Officer

Officer
59,000
34.20
US$2,017,800
59,000 34.20 US$2,017,800